DNB NXT Healthcare Venture Session and DNB Healthcare Prize 2022

15 desember
09:00 - 16:30

DNB's head office, Dronning Eufemias gate 30, Oslo

DNB NXT Healthcare Venture Session at DNB Nordic Healthcare Conference 2022, organized by DNB together with Norway Health Tech and Oslo Cancer Cluster, is a unique opportunity to meet interested investors.

We are happy to announce that this year, the DNB Healthcare Prize, an award of NOK 1 million, again will be a part of the conference. The DNB NXT Healthcare Venture Session and the DNB Healthcare Prize will be one session.


The panel of professional investors on stage during the DNB Healthcare Prize Final

The panel will consist of professional healthcare industry investors and a representative from DNB Markets IBD.

The panel will be sitting on the stage, beside the companies presenting in the final.

The investor panel will have the opportunity to ask the finalists questions to reveal the attractiveness of each company from the investor point of view.

Venture Session

11 companies are selected by a professional jury to present at the DNB NXT Healthcare Venture Session. They will all be awarded with having their logos displayed on Nasdaq’s boards on Times Square.

Arxx Therapeutics 


Kongsberg Beam Technology 

Adjutec Pharma 






DNB NXT Healthcare Prize Nominees

Three companies have been chosen by the Jury to compete for the 1 Million NOK Prize. The fourth company will be chosen by the audience at the conference.



Domore Diagnostics